{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Fbtki-therapy-for-mcl-icml-2023-gStRtnln","width":444,"version":"1.0","type":"rich","title":"New Evidence With BTK Inhibitor Therapy in MCL From ICML 2023 ","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/56b8718b-8344-47af-960a-d9f2bba722c1/cll-mcl-cf-heme-annual-6497-icml-podcast-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/e00c4d12-d8a9-4c4a-a914-3c7465427ad4\" height=\"200\" width=\"100%\" title=\"New Evidence With BTK Inhibitor Therapy in MCL From ICML 2023 \" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Gain insight into expert faculty perspectives as they discuss recent key studies from ICML 2023 on BTK inhibition in mantle cell lymphoma and their potential implications for clinical practice."}